MPL-C: Began Phase II trials

Ribi ImmunoChem Research Inc. (RIBI) Product: MPL-C, injectable monophosphoral lipid A derived from bacterial endotoxin Indication: Coronary artery bypass graft surgery patients at risk of post-bypass...